Nation and world news briefs

US-run clinical trial of Eli Lilly antibody therapy to endEli Lilly & Co. said a clinical trial of its experimental antibody therapy in hospitalized COVID-19 patients will end, after the U.S. government-run study was paused earlier this month.The company said in a statement that the decision was based on data suggesting the treatment is unlikely to help hospitalized COVID-19 patients recover from the advanced stage of their disease.On Oct. 14, the Indianapolis drug giant said enrollment had been paused in the so-called ACTIV-3 trial of its neutralizing monoclonal antibody treatment sponsored b…

Read More

HEDGE accordingly